Results 241 to 250 of about 107,625 (303)

A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PF‐07261271 in healthy participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim There is an unmet need for more effective therapies in inflammatory bowel disease (IBD). A single drug that blocks multiple distinct pathogenic pathways may offer therapeutic benefit superior to current monotherapies. PF‐07261271, a bispecific antibody targeting both the p40 subunit of interleukin‐12/23 and tumour necrosis factor‐like cytokine 1A ...
Srividya Neelakantan   +11 more
wiley   +1 more source

Effects of Continuous Postoperative Pericardial FLUshing with Investigational Device on Postoperative Re-Explorations for Bleeding (FLUID)-Randomized Clinical Trial. [PDF]

open access: yesJ Clin Med
Molenaar MA   +15 more
europepmc   +1 more source

Reverse Osmosis Membrane Cleaning Optimization from Textile Dyeing Wastewater Reuse Applications. [PDF]

open access: yesMembranes (Basel)
Wang Z   +7 more
europepmc   +1 more source

Influence of Flushing Velocity and Flushing Frequency on the Service Life of Labyrinth-Channel Emitters

open access: yesWater (Switzerland), 2018
Dripline flushing is an effective way to relieve emitter clogging and extend the longevity of drip irrigation systems. This laboratory study was conducted at Kunming University of Science and Technology to evaluate the effect of three targeted flushing ...
Ningbo Cui, Cui Ningbo
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Disorders of Flushing

Comprehensive Therapy, 2005
Disorders of flushing encompass a broad spectrum of diverse acquired and inherited conditions. Chemical mediators involved in the flushing response are incompletely understood. Flushing episodes rarely can be associated with significant morbidity and mortality. The goal of the physician is to separate benign from potentially life-threatening conditions.
Steven H, Yale   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy